Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient Decision Aid for Chemotherapy or Exclusion in Cisplatin-Intolerant Patients With Locally Advanced Cervical Cancer (CECIL): Development, Validation and Clinical Testing

NCT05701735 is registered in ClinicalTrials.gov with University of Santo Tomas Hospital, Philippines as lead sponsor.

NCT NCT05701735
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05701735 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient Decision Aid for Chemotherapy or Exclusion in Cisplatin-Intolerant Patients With Locally Advanced Cervical Cancer (CECIL): Development, Validation and Clinical Testing
Lead sponsor
University of Santo Tomas Hospital, Philippines
Phase
Not applicable
Overall status
Unknown status
Start date
February 20, 2023
Completion date
December 31, 2024
Enrollment
45 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced cervical carcinoma